ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (0R2M)

296.60
0.00
( 0.00% )
Updated: 19:00:00

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 6.97B8.76B11.73B14.81B17.16B25.43B29.21B33.08B
Total Current Assets 3.18B4.34B6.45B7.69B9.78B14.01B15.88B19.48B
Cash and Equivalents 535.2M812.73M1.47B1.62B2.19B2.89B3.11B2.73B
Total Non-Current Assets 4.45B6.14B8.76B11.09B11.03B18.77B22.66B25.97B
Total Liabilities 2.52B2.62B2.98B3.72B6.14B6.67B6.55B7.11B
Total Current Liabilities 1.24B1.14B1.44B2.1B2.7B3.93B3.14B3.42B
Total Non-Current Liabilities 1.63B2.19B2.24B2.33B6.14B4.71B6.11B6.39B
Total Equity 4.45B6.14B8.76B11.09B11.03B18.77B22.66B25.97B
Common Equity 110k112k100k100k100k100k100k100k
Retained Earnings 1.75B2.95B5.25B7.38B10.89B18.97B23.31B27.26B